PC
ALDR

Polar Capital’s Alder Biopharmaceuticals ALDR Stock Holding History

Polar Capital’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-250,000
Closed -$2.86M – 284
2017
Q4 		$2.86M Buy
+250,000
New +$2.79M 0.03% 226
2017
Q1 		– Sell
-100,000
Closed -$2.08M – 280
2016
Q4 		$2.08M Buy
100,000
+25,000
+33% +$650K 0.03% 227
2016
Q3 		$2.46M Hold
75,000
– – 0.04% 210
2016
Q2 		$1.87M Buy
+75,000
New +$2.03M 0.04% 226
2015
Q2 		– Sell
-128,461
Closed -$3.71M – 312
2015
Q1 		$3.71M Buy
128,461
+102,865
+402% +$2.82M 0.07% 188
2014
Q4 		$745K Buy
+25,596
New +$459K 0.01% 245

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return